{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:54:26Z","timestamp":1782960866579,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer characterized by rapid tumor growth and early metastasis. Accurate prediction of prognosis and therapeutic response is crucial for optimizing treatment strategies and improving patient outcomes. In this study, we conducted a deep-learning analysis of Hematoxylin and Eosin (H&amp;E) stained histopathological images using contrastive clustering and identified 50 intricate histomorphological phenotype clusters (HPCs) as pathomic features. We identified two of 50 HPCs with significant prognostic value and then integrated them into a pathomics signature (PathoSig) using the Cox regression model. PathoSig showed significant risk stratification for overall survival and disease-free survival and successfully identified patients who may benefit from postoperative or preoperative chemoradiotherapy. The predictive power of PathoSig was validated in independent multicenter cohorts. Furthermore, PathoSig can provide comprehensive prognostic information beyond the current TNM staging system and molecular subtyping. Overall, our study highlights the significant potential of utilizing histopathology images-based deep learning in improving prognostic predictions and evaluating therapeutic response in SCLC. PathoSig represents an effective tool that aids clinicians in making informed decisions and selecting personalized treatment strategies for SCLC patients.<\/jats:p>","DOI":"10.1038\/s41746-024-01003-0","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:03:33Z","timestamp":1705593813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer"],"prefix":"10.1038","volume":"7","author":[{"given":"Yibo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruanqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-4118","authenticated-orcid":false,"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9987-9024","authenticated-orcid":false,"given":"Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"1003_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1003_CR2","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","volume":"378","author":"JP van Meerbeeck","year":"2011","unstructured":"van Meerbeeck, J. P., Fennell, D. A. & De Ruysscher, D. K. Small-cell lung cancer. Lancet 378, 1741\u20131755 (2011).","journal-title":"Lancet"},{"key":"1003_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers, L. A. & Rudin, C. M. Small cell lung cancer: where do we go from here? Cancer 121, 664\u2013672 (2015).","journal-title":"Cancer"},{"key":"1003_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","volume":"39","author":"CM Gay","year":"2021","unstructured":"Gay, C. M. et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39, 346\u2013360.e347 (2021).","journal-title":"Cancer Cell"},{"key":"1003_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29517-9","volume":"13","author":"D Lissa","year":"2022","unstructured":"Lissa, D. et al. Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. Nat. Commun. 13, 2023 (2022).","journal-title":"Nat. Commun."},{"key":"1003_CR6","doi-asserted-by":"publisher","first-page":"106844","DOI":"10.1016\/j.phrs.2023.106844","volume":"194","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities. Pharmacol. Res. 194, 106844 (2023).","journal-title":"Pharmacol. Res."},{"key":"1003_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jtho.2019.01.019","volume":"14","author":"X Zhao","year":"2019","unstructured":"Zhao, X. et al. Surgical resection of SCLC: prognostic factors and the tumor microenvironment. J. Thorac. Oncol. 14, 914\u2013923 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"1003_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-01953-2","volume":"19","author":"H Yang","year":"2021","unstructured":"Yang, H. et al. Deep learning-based six-type classifier for lung cancer and mimics from histopathological whole slide images: a retrospective study. BMC Med. 19, 80 (2021).","journal-title":"BMC Med."},{"key":"1003_CR9","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-19-1495","volume":"26","author":"PM Kulkarni","year":"2020","unstructured":"Kulkarni, P. M. et al. Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death. Clin. Cancer Res. 26, 1126\u20131134 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1003_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00275-7","volume":"6","author":"T Qaiser","year":"2022","unstructured":"Qaiser, T. et al. Usability of deep learning and H&E images predict disease outcome-emerging tool to optimize clinical trials. NPJ Precis. Oncol. 6, 37 (2022).","journal-title":"NPJ Precis. Oncol."},{"key":"1003_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin, C. M. et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat. Rev. Cancer 19, 289\u2013297 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1003_CR12","doi-asserted-by":"publisher","first-page":"103194","DOI":"10.1016\/j.critrevonc.2020.103194","volume":"157","author":"EN Imyanitov","year":"2021","unstructured":"Imyanitov, E. N., Iyevleva, A. G. & Levchenko, E. V. Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives. Crit. Rev. Oncol. Hematol. 157, 103194 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1003_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1101\/gad.338228.120","volume":"34","author":"G Ferone","year":"2020","unstructured":"Ferone, G., Lee, M. C., Sage, J. & Berns, A. Cells of origin of lung cancers: lessons from mouse studies. Genes Dev. 34, 1017\u20131032 (2020).","journal-title":"Genes Dev."},{"key":"1003_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/JTO.0000000000000459","volume":"10","author":"AF Gazdar","year":"2015","unstructured":"Gazdar, A. F. et al. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J. Thorac. Oncol. 10, 553\u2013564 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrc.2017.87","volume":"17","author":"AF Gazdar","year":"2017","unstructured":"Gazdar, A. F., Bunn, P. A. & Minna, J. D. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat. Rev. Cancer 17, 725\u2013737 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1003_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00408-021-00486-y","volume":"199","author":"S Tariq","year":"2021","unstructured":"Tariq, S., Kim, S. Y., Monteiro de Oliveira Novaes, J. & Cheng, H. Update 2021: management of small cell lung cancer. Lung 199, 579\u2013587 (2021).","journal-title":"Lung"},{"key":"1003_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/labinvest.2017.131","volume":"98","author":"P Bankhead","year":"2018","unstructured":"Bankhead, P. et al. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer. Lab. Invest. 98, 15\u201326 (2018).","journal-title":"Lab. Invest."},{"key":"1003_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ebiom.2019.10.033","volume":"50","author":"S Wang","year":"2019","unstructured":"Wang, S. et al. ConvPath: a software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural network. EBioMedicine 50, 103\u2013110 (2019).","journal-title":"EBioMedicine"},{"key":"1003_CR19","doi-asserted-by":"publisher","first-page":"779276","DOI":"10.3389\/fonc.2022.779276","volume":"12","author":"J Qi","year":"2022","unstructured":"Qi, J., Zhang, J., Liu, N., Zhao, L. & Xu, B. Prognostic implications of molecular subtypes in primary small cell lung cancer and their correlation with cancer immunity. Front. Oncol. 12, 779276 (2022).","journal-title":"Front. Oncol."},{"key":"1003_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.lungcan.2021.06.026","volume":"160","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes. Lung Cancer 160, 166\u2013174 (2021).","journal-title":"Lung Cancer"},{"key":"1003_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12957-022-02528-y","volume":"20","author":"XL Ding","year":"2022","unstructured":"Ding, X. L. et al. Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC). World. J. Surg. Oncol. 20, 54 (2022).","journal-title":"World. J. Surg. Oncol."},{"key":"1003_CR22","doi-asserted-by":"publisher","first-page":"100184","DOI":"10.1016\/j.modpat.2023.100184","volume":"36","author":"S Hwang","year":"2023","unstructured":"Hwang, S. et al. Whole-section landscape analysis of molecular subtypes in curatively resected small cell lung cancer: clinicopathologic features and prognostic significance. Mod Pathol 36, 100184 (2023).","journal-title":"Mod Pathol"},{"key":"1003_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","volume":"17","author":"JL Sauter","year":"2022","unstructured":"Sauter, J. L. et al. The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification. J. Thorac. Oncol. 17, 608\u2013622 (2022).","journal-title":"J. Thorac. Oncol."},{"key":"1003_CR24","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1609\/aaai.v35i10.17037","volume":"35","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Contrastive clustering. The Thirty-Fifth AAAI Conference on Artificial Intelligence (AAAI-21) 35, 8547\u20138555 (2021).","journal-title":"The Thirty-Fifth AAAI Conference on Artificial Intelligence (AAAI-21)"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01003-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01003-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01003-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:17:15Z","timestamp":1705594635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01003-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1038\/s41746-024-01003-0","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}